您的位置: 首页 > 农业专利 > 详情页

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
专利权人:
Inc.;Merrimack Pharmaceuticals
发明人:
Bayever, Eliel,Dhindsa, Navreet,Fitzgerald, Jonathan Basil,Laivins, Peter,Moyo, Victor,Niyikiza, Clet
申请号:
AU2013202947
公开号:
AU2013202947A1
申请日:
2013.04.08
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
#$%^&*AU2013202947A120140116.pdf#####METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN 5 Abstract of the Disclosure Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin. 10 - 59 -
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充